Cigna Investments’s iRadimed IRMD Stock Holding History

Cigna Investments’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,539	Closed	-$91K	–	900
2017 Q2	$91K	Buy	10,539 +417	+4%	+$3.56K	0.01%	822
2017 Q1	$90K	Buy	+10,122	New	+$93.8K	0.01%	739

Other funds holding IRMD

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cigna Investments's IRMD Position: Q3 2017 in Review

Cigna Investments sold out of iRadimed (IRMD) in Q3 2017, closing a stake of 10,539 shares — an estimated $91K sold.

Cigna Investments first reported a position in IRMD in Q1 2017 and held it in 2 quarters. The position peaked at $91K in Q2 2017. 29 funds tracked by Wall St. Rank hold IRMD as of Q3 2017.

Cigna Investments reported no remaining iRadimed position as of Q3 2017 after selling out during the quarter.
Cigna Investments sold 10,539 iRadimed shares in Q3 2017, an estimated $91K.
Cigna Investments first reported a position in iRadimed in Q1 2017 and held it in 2 quarters.
Cigna Investments's iRadimed position peaked at $91K in Q2 2017.
29 funds tracked by Wall St. Rank held iRadimed as of Q3 2017.

Based on Cigna Investments's 13F filing for Q3 2017, filed 11 Oct 2017.